TY - JOUR
T1 - Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis
AU - Aguilar-Company, Juan
AU - Los-Arcos, Ibai
AU - Pigrau, Carles
AU - Rodríguez-Pardo, Dolors
AU - Larrosa, María Nieves
AU - Rodríguez-Garrido, Virginia
AU - Sihuay-Diburga, Denisse
AU - Almirante, Benito
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Copyright © 2016, American Society for Microbiology. All Rights Reserved. We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.
AB - Copyright © 2016, American Society for Microbiology. All Rights Reserved. We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.
UR - https://www.scopus.com/pages/publications/84976877480
U2 - 10.1128/AAC.00447-16
DO - 10.1128/AAC.00447-16
M3 - Article
SN - 0066-4804
VL - 60
SP - 4398
EP - 4400
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 7
ER -